Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/24/2018
CBT and CrystalGenomics Announce Partnership to Co-develop I/O Therapy
4/24/2018
Merck Group Receives Patent for CRISPR Technology in China
4/24/2018
Gibson: U.S.'s Growing Dependence on China For Vital Medicines A Natio...
4/24/2018
Simcere, Hitgen Enter Partnership and License for New Drug Discovery
4/24/2018
The Biosimilar Race in China
4/23/2018
CDE Publicizes Batch 28 of Drug Applications To Be Granted Priority Re...
4/23/2018
China-Denmark Drug Regulatory Thematic Seminar held in Beijing
4/19/2018
Tocagen Licenses Greater China Rights for Phase III Cancer Immunothera...
4/19/2018
Sinovac Announces Preliminary Results of Phase III Trial on sIPV
4/19/2018
Recent Executive Moves
4/19/2018
CDE Releases Two Draft Clinical Guidelines for Public Comments
4/19/2018
CNDA Solicits Comments on Clinical Guidelines for Acute Heart Failure ...
4/19/2018
Pfenex and NT Pharma Agree over Bioequivalent Generic of Forteo
4/19/2018
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Serv...
4/19/2018
Breaking News on New Policies of Innovative Drugs in China
4/18/2018
Chinese Money Floods U.S. Biotech as Beijing Chases New Cures
4/18/2018
China Publishes First Health Management Bluebook
4/18/2018
Takeda Launches Multiple Myeloma Drug Ninlaro in China
4/18/2018
CNDA Outlines Five Focal Areas of Its Work in 2018
4/18/2018
Morphotek Licenses Its Eribulin-Linker Payload To Bliss Bio
4/18/2018
China Announces New Initiatives to Level the Playing Field for Innovat...
4/17/2018
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients
4/17/2018
U.S. Businesses Worried over Chinese Policy Initiative
4/17/2018
China Will Always Be Bad at Bioethics
4/17/2018
Why Immuno-Therapy Is Leaving Markets Abuzz Across the World
4/17/2018
Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race
4/17/2018
Alliance Pharma Sells Chinese JV and Rights of Pregnancy Supplement fo...
4/17/2018
China Performance of Korean Pharma Cos Mixed in 2017 with Hanmi and Il...
4/17/2018
GlobalData: Chinese Pharma Regulatory Reforms to Help Attract Foreign ...
4/17/2018
China to Cut Review Time for Clinical Trial Applications with Plan to ...
Page:
272
/
720
Total number of articles:
21578
:
[First]
[<<]
[270]
[271]
[272]
[273]
[274]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit